| LUDWIG, H., Zdeněk ADAM, R. GREIL, E. TÓTHOVÁ, F. KEIL, N. ZOJER, J. THALER, H. GISSLINGER, M. EGYED and A. LANG. Reversal of acute renal impairment by bortezomib-doxorubicin-dexamathasone in multiple myeloma. Results from an phase II study. 2009. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{836782,
author = {Ludwig, H. and Adam, Zdeněk and Greil, R. and Tóthová, E. and Keil, F. and Zojer, N. and Thaler, J. and Gisslinger, H. and Egyed, M. and Lang, A.},
keywords = {multiple myeloma; dexamethasone; bortezomib;doxorubicin},
language = {eng},
title = {Reversal of acute renal impairment by bortezomib-doxorubicin-dexamathasone in multiple myeloma. Results from an phase II study},
year = {2009}
}
TY - CONF
ID - 836782
AU - Ludwig, H. - Adam, Zdeněk - Greil, R. - Tóthová, E. - Keil, F. - Zojer, N. - Thaler, J. - Gisslinger, H. - Egyed, M. - Lang, A.
PY - 2009
TI - Reversal of acute renal impairment by bortezomib-doxorubicin-dexamathasone in multiple myeloma. Results from an phase II study
KW - multiple myeloma
KW - dexamethasone
KW - bortezomib;doxorubicin
ER -
LUDWIG, H., Zdeněk ADAM, R. GREIL, E. TÓTHOVÁ, F. KEIL, N. ZOJER, J. THALER, H. GISSLINGER, M. EGYED and A. LANG. \textit{Reversal of acute renal impairment by bortezomib-doxorubicin-dexamathasone in multiple myeloma. Results from an phase II study}. 2009.
|
